 |
|
Secondary Hyperparathyroidism and Bone Disease in Infants Receiving Long-term Furosemide Therapy
Pankaja S. Venkataraman, MBBS;
Bokyung K. Han, MD;
Reginald C. Tsang, MBBS;
Cynthia C. Daugherty, MD
Am J Dis Child. 1983;137(12):1157-1161.
Abstract
• Four preterm infants receiving long-term furosemide therapy were examined for hypercalciuria, hyperparathyroidism, renal calcification, and bone demineralization. All four infants had increased urinary calcium excretion. Three infants had high serum concentrations of parathyroid hormone, and in these three infants, bone mineral content was below the mean of "osteopenic" preterm infants of comparable gestational and postnatal age. In two of these infants, there was ultrasound evidence of renal calcification. In one infant, autopsy disclosed bone changes of hyperparathyroidism, gallstones, and calcification in the heart and kidney.
(Am J Dis Child 1983;137:1157-1161)
Author Affiliations
From the Newborn (Drs Venkataraman and Tsang), Radiology (Dr Han), and Pathology (Dr Daugherty) Divisions, Department of Pediatrics, Children's Hospital Medical Center, Cincinnati, and the University of Cincinnati College of Medicine. Dr Venkataraman is now with the University of Oklahoma Health Sciences Center, Oklahoma City.
Footnotes
Presented in part before the Fifth Workshop on Vitamin D, Williamsburg, Va, Feb 15, 1982.
Reprint requests to University of Oklahoma Health Sciences Center, PO Box 26901, Oklahoma City, OK 73190 (Dr Venkataraman).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Diuretics and Bone Loss in Rats With Aldosteronism
Law et al.
J Am Coll Cardiol 2005;46:142-146.
ABSTRACT
| FULL TEXT
Pulmonary Effect of Inhaled Furosemide in Ventilated Infants With Severe Bronchopulmonary Dysplasia
Kugelman et al.
Pediatrics 1997;99:71-75.
ABSTRACT
| FULL TEXT
|
